Zhang Yi, Wang Bin, Hu Junchao, Yin Tianyuan, Yue Tao, Liu Na, Liu Yuanyuan
School of Mechatronic Engineering and Automation, Shanghai University, Shanghai 200444, China.
Int J Bioprint. 2020 Dec 4;7(1):299. doi: 10.18063/ijb.v7i1.299. eCollection 2021.
Three-dimensional (3D) bioprinting is an important technology for fabricating artificial tissue. To effectively reconstruct the multiscale structure and multi-material gradient of natural tissues and organs, 3D bioprinting has been increasingly developed into multi-process composite mode. The current 3D composite bioprinting is a combination of two or more printing processes, and oftentimes, physical field regulation that can regulate filaments or cells during or after printing may be involved. Correspondingly, both path planning strategy and process control all become more complex. Hence, the computer-aided design and computer-aided manufacturing (CAD/CAM) system that is traditionally used in 3D printing system is now facing challenges. Thus, the scale information that cannot be modeled in the CAD process should be considered in the design of CAM by adding a process management module in the traditional CAD/CAM system and add more information reflecting component gradient in the path planning strategy.
三维(3D)生物打印是制造人造组织的一项重要技术。为了有效重建天然组织和器官的多尺度结构及多材料梯度,3D生物打印已日益发展为多工艺复合模式。当前的3D复合生物打印是两种或更多打印工艺的结合,并且通常可能涉及在打印过程中或打印后能够调节细丝或细胞的物理场调控。相应地,路径规划策略和过程控制都变得更加复杂。因此,传统上用于3D打印系统的计算机辅助设计和计算机辅助制造(CAD/CAM)系统如今正面临挑战。所以,应通过在传统CAD/CAM系统中添加过程管理模块,在计算机辅助制造(CAM)设计中考虑在CAD过程中无法建模的尺度信息,并在路径规划策略中添加更多反映部件梯度的信息。